The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping
Open accessAbstract
Gastroenteropancreatic (GEP) neuroendocrine neoplasm (NEN) that consists of neuroendocrine tumor and neuroendocrine carcinoma (NEC) is a lethal but under-investigated disease owing to its rarity. To fill the scarcity of clinically relevant models of GEP-NEN, we here established 25 lines of NEN organoids and performed their comprehensive molecular characterization. GEP-NEN organoids recapitulated pathohistological and functional phenotypes of the original tumors. Whole-genome sequencing revealed frequent genetic alterations in TP53 and RB1 in GEP-NECs, and characteristic chromosome-wide loss of heterozygosity in GEP-NENs. Transcriptome analysis identified molecular subtypes that are distinguished by the expression of distinct transcription factors. GEP-NEN organoids gained independence from the stem cell niche irrespective of genetic mutations. Compound knockout of TP53 and RB1, together with overexpression of key transcription factors, conferred on the normal colonic epithelium phenotypes that are compatible with GEP-NEN biology. Altogether, our study not only provides genetic understanding of GEP-NEN, but also connects its genetics and biological phenotypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They showed that while cells from tumorspheres displayed a solid growth pattern, organoids were more diffusive, similar to the tumor of origin172.”
From Organoids (2022) · cites this paper as [172]
In the citing paper
“These tumoroid biobanks can then be used as in vitro models of tumorigenesis and offer a significant advantage over conventional 2D cell culture technology5,6.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [5]
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Research works printed but not linked: 1
- WHO Classification of Tumours Editorial Board, 2019. Digestive System Tumours. Fifth Edition. International Agency for Research on Cancer.
Cited by
Sorted by citations
Zhao, Z., Chen, X., Dowbaj, A. M., Sljukic, A., Bratlie, K., Lin, L., Fong, E. L. S., Balachander, G. M., Chen, Z., Soragni, A., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00174-y · Cited by 1,082
Tumor organoids: Opportunities and challenges to guide precision medicine
Veninga, V., & Voest, E. E. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.07.020 · Cited by 339
Organoids: The current status and biomedical applications
Yang, S., Hu, H., Kung, H., Zou, R.-Q., Dai, Y.-S., Hu, Y.-F., Wang, T., Lv, T., Yu, J., & Li, F. (2023) · MedComm · doi:10.1002/mco2.274 · Cited by 300
WNT as a Driver and Dependency in Cancer
Parsons, M. J., Tammela, T., & Dow, L. E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0190 · Cited by 257
Mechanisms of small cell lung cancer metastasis
Ko, J. H., Winslow, M. M., & Sage, J. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202013122 · Cited by 236
Thorel, L., Perréard, M., Florent, R., Divoux, J., Coffy, S., Vincent, A., Gaggioli, C., Guasch, G., Gidrol, X., Weiswald, L.-B., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01272-5 · Cited by 236
Promises and challenges of organoid-guided precision medicine
Bose, S., Clevers, H., & Shen, X. (2021) · Med · doi:10.1016/j.medj.2021.08.005 · Cited by 213
Clinical applications of human organoids
Verstegen, M. M. A., Coppes, R. P., Béghin, A., Coppi, P. D., Gerli, M., de Graeff, N., Pan, Q., Saito, Y., Shi, S., ZADPOOR, A. A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03489-3 · Cited by 230
Self-citationPatient-derived organoids in precision cancer medicine
Tong, L., Cui, W., Zhang, B., Fonseca, P., Zhao, Q. C., Zhang, P., Xu, B., Zhang, Q., Li, Z., Seashore-Ludlow, B. A., et al. (2024) · Med · doi:10.1016/j.medj.2024.08.010 · Cited by 192
Organoid cultures for cancer modeling
Yan, H. H. N., Chan, A., Lai, F. P.-L., & Leung, S. Y. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.05.012 · Cited by 176
Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Yachida, S., Totoki, Y., Noë, M., Nakatani, Y., Horie, M., Kawasaki, K., Nakamura, H., Saito-Adachi, M., Suzuki, M., Takai, E., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0669 · Cited by 161
Self-citationOrganoids in gastrointestinal diseases: From experimental models to clinical translation
Günther, C., Winner, B., Neurath, M. F., & Stappenbeck, T. S. (2022) · Gut · doi:10.1136/gutjnl-2021-326560 · Cited by 145
3D cell cultures toward quantitative high-throughput drug screening
Wang, Y., & Jeon, H. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.03.014 · Cited by 143
Human organoids-on-chips for biomedical research and applications
Wang, H., Ning, X., Zhao, F. H., Zhao, H., & Li, D. (2024) · Theranostics · doi:10.7150/thno.90492 · Cited by 148
van Riet, J., van de Werken, H. J. G., Cuppen, E. P. J. G., Eskens, F. A. L. M., Tesselaar, M. E. T., van Veenendaal, L. M., Klümpen, H., Dercksen, M. W., Valk, G. D., Lolkema, M. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24812-3 · Cited by 135
Organoids are not organs: Sources of variation and misinformation in organoid biology
Jensen, K. B., & Little, M. H. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.05.009 · Cited by 127
3D and organoid culture in research: physiology, hereditary genetic diseases and cancer
Suarez-Martinez, E., Suazo-Sanchez, I., Celis-Romero, M., & Carnero, A. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00775-w · Cited by 118
Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Yachida, S., Totoki, Y., Noë, M., Nakatani, Y., Horie, M., Kawasaki, K., Nakamura, H. K., Saito-Adachi, M., Suzuki, M., Takai, E., et al. (2022) · Utrecht University Repository (Utrecht University) · Cited by 112
Self-citationXiang, D., He, A., Zhou, R., Wang, Y., Xiao, X., Gong, T., Kang, W., Lin, X., Wang, X., Consortium11, P.-B. D., et al. (2024) · Theranostics · doi:10.7150/thno.96027 · Cited by 108
CRISPR engineering in organoids for gene repair and disease modelling
Geurts, M. H., & Clevers, H. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00013-5 · Cited by 103
Shi, X., Li, Y., Yuan, Q., Tang, S., Guo, S., Zhang, Y., He, J., Zhang, X., Han, M., Liu, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29857-6 · Cited by 103
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
Yao, J. C., Bergsland, E. K., Aggarwal, R. R., Aparicio, A. M., Beltran, H., Crabtree, J. S., Hann, C. L., Ibrahim, T., Byers, L. A., Sasano, H., et al. (2022) · The Oncologist · doi:10.1093/oncolo/oyac161 · Cited by 98
Yao, Q., Cheng, S., Pan, Q., Yu, J., Cao, G., Li, L., & Cao, H. (2024) · MedComm · doi:10.1002/mco2.735 · Cited by 100
Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment
Zhu, Y., Cui, Y., Zheng, X., Zhao, Y. M., & Sun, G. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166557 · Cited by 94
Dayton, T. L., Alcala, N., Moonen, L., den Hartigh, L., Geurts, V., Mangiante, L., Lap, L. M. V., Dost, A. F. M., Beumer, J., Levy, S., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.11.007 · Cited by 89
Clinical application of a lung cancer organoid (tumoroid) culture system
Yokota, E., Iwai, M., Yukawa, T., Yoshida, M., Naomoto, Y., Haisa, M., Monobe, Y., Takigawa, N., Guo, M., Maeda, Y., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00166-3 · Cited by 85
Construction of tumor organoids and their application to cancer research and therapy
Lv, J., Du, X., Wang, M., Su, J., Wei, Y., & Xu, C. (2024) · Theranostics · doi:10.7150/thno.91362 · Cited by 90
Ebisudani, T., Hamamoto, J., Togasaki, K., Mitsuishi, A., Sugihara, K., Shinozaki, T., Fukushima, T., Kawasaki, K., Seino, T., Oda, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112212 · Cited by 81
Self-citationKawasaki, K., Rekhtman, N., Quintanal-Villalonga, À., & Rudin, C. M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00696-0 · Cited by 71
Self-citationWang, E., Xiang, K., Zhang, Y., & Wang, X.-F. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.10.001 · Cited by 56
Patient‐derived cancer organoids for drug screening: Basic technology and clinical application
Ren, X., Chen, W., Yang, Q., Li, X., & Xu, L. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15930 · Cited by 73
One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids
Geurts, M. H., Gandhi, S., Boretto, M. G., Akkerman, N., Derks, L. L. M., van Son, G., Celotti, M., Harshuk-Shabso, S., Peci, F., Begthel, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40701-3 · Cited by 66
“These tumoroid biobanks can then be used as in vitro models of tumorigenesis and offer a signi fi cant advantage over conventional 2D cell culture technology 5,6 .”
Organoids and Colorectal Cancer
Barbáchano, A., Fernández‐Barral, A., Bustamante‐Madrid, P., Prieto, I., Rodríguez-Salas, N., Larriba, M. J., & Múñoz, A. (2021) · Cancers · doi:10.3390/cancers13112657 · Cited by 74
Wang, Z., Liu, C., Zheng, S., Yao, Y., Wang, S., Wang, X., Yin, E., Zeng, Q., Zhang, C., Zhang, G., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.05.002 · Cited by 65
Tumor organoid biobank-new platform for medical research
Xie, X., Li, X., & Song, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-29065-2 · Cited by 70
Sun, L., Kang, X., Ju, H., Wang, C., Yang, G., Wang, R., & Sun, S. (2023) · Science Advances · doi:10.1126/sciadv.adg6686 · Cited by 59
Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor Organoids
Gillette, A. A., Babiarz, C. P., VanDommelen, A. R., Pasch, C. A., Clipson, L. J., Matkowskyj, K. A., Deming, D. A., & Skala, M. C. (2021) · Cancers · doi:10.3390/cancers13081873 · Cited by 57
Cancer organoids: A platform in basic and translational research
Ma, X., Wang, Q. L., Li, G., Li, H., Xu, S., & Pang, D. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.052 · Cited by 62
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
Taurin, S., Alzahrani, R., Aloraibi, S., Ashi, L., AlHarmi, R. A. R., & Hassani, N. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102226 · Cited by 57
García‐Carbonero, R., Antón-Pascual, B., Modrego, A., Martínez, M. C. R., Lens‐Pardo, A., Carretero-Puche, C., Rubio-Cuesta, B., & Soldevilla, B. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad006 · Cited by 52
From organoids to organoids-on-a-chip: Current applications and challenges in biomedical research
Liu, K., Chen, X., Fan, Z., Ren, F., Liu, J., & Hu, B. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003535 · Cited by 59
Gastrointestinal cancer organoids—applications in basic and translational cancer research
Seidlitz, T., & Stange, D. E. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00654-3 · Cited by 52
Jose, A., Kulkarni, P., Thilakan, J., Munisamy, M., Malhotra, A. G., Singh, J., Kumar, A., Rangnekar, V. M., Arya, N., & Rao, M. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01916-6 · Cited by 49
Reconstructing the tumor architecture into organoids
Luo, Z., Zhou, X., Mandal, K., He, N., Wennerberg, W., Qu, M., Jiang, X., Sun, W., & Khademhosseini, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113839 · Cited by 49
A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens
Price, S., Bhosle, S. G., Gonçalves, E., Li, X., McClurg, D. P., Barthorpe, S., Beck, A., Hall, C., Lightfoot, H. W., Farrow, L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09508-y · Cited by 47
Modeling Intestinal Stem Cell Function with Organoids
Takahashi, T., Fujishima, K., & Kengaku, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010912 · Cited by 45
Harnessing the power of artificial intelligence for human living organoid research
Wang, H., Li, X., You, X., & Zhao, G. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.08.027 · Cited by 43
Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma
Dijkstra, K. K., van den Berg, J. G., Weeber, F., van de Haar, J., Velds, A., Kaing, S., Peters, D. D. G. C., Eskens, F. A. L. M., de Groot, D. J., Tesselaar, M. E. T., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.627819 · Cited by 42
Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma
Frizziero, M., Kilgour, E., Simpson, K., Rothwell, D. G., Moore, D. A., Frese, K. K., Galvin, M., Lamarca, Á., Hubner, R. A., Valle, J. W., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3058 · Cited by 41
Living biobank: Standardization of organoid construction and challenges
Yang, R., Yao, Q., Zhang, X., Gao, H., & Yu, Y. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003414 · Cited by 40
Decoding the basis of histological variation in human cancer
Fujii, M., Sekine, S., & Sato, T. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00648-5 · Cited by 35
Self-citationOrganoid‐Guided Precision Medicine: From Bench to Bedside
Tao, B., Li, X., Hao, M., Tian, T., Li, Y., Li, X., Yang, C., Li, Q., Feng, Q., Zhou, H., et al. (2025) · MedComm · doi:10.1002/mco2.70195 · Cited by 38
Griger, J., Widholz, S. A., Jesinghaus, M., Krätzig, N. D. A., Lange, S., Engleitner, T., Montero, J. J., Zhigalova, E., Öllinger, R., Suresh, V., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2023.06.001 · Cited by 35
Gao, J., Lan, J., Liao, H., Yang, F., Qiu, P., Jin, F., Wang, S., Shen, L., Chao, T., Zhang, C., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11434-9 · Cited by 37
Translational models of 3-D organoids and cancer stem cells in gastric cancer research
Wuputra, K., Ku, C., Kato, K., Wu, D., Saito, S., & Yokoyama, K. K. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02521-4 · Cited by 33
Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
Li, Z., Xu, H., Gong, Y., Chen, W., Zhan, Y., Yu, L., Sun, Y., Li, A., He, S., Guan, B., et al. (2021) · Advanced Science · doi:10.1002/advs.202103999 · Cited by 32
Uccella, S. (2024) · Endocrine Pathology · doi:10.1007/s12022-024-09807-2 · Cited by 32
Reimagining human-centric drug development with new approach methodologies
Wu, X., Wu, M. A., Zou, J., Kleinstreuer, N., & Wu, J. C. (2026) · Science · doi:10.1126/science.aeb0045 · Cited by 37
In-Depth Comparison of Matrigel Dissolving Methods on Proteomic Profiling of Organoids
Wang, M., Yu, H., Zhang, T., Cao, L., Du, Y., Xie, Y., Ji, J., & Wu, J. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100181 · Cited by 34
Verginelli, F., Pisacane, A. M., Gambardella, G., D’Ambrosio, A., Candiello, E., Ferrio, M., Panero, M., Casorzo, L., Benvenuti, S., Cascardi, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22643-w · Cited by 30
Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety.
Botti, G., Bonito, M. D., & Cantile, M. (2021) · PubMed Central · Cited by 27
Waehle, V., Ungricht, R., Hoppe, P. S., & Betschinger, J. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.07.023 · Cited by 29
Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma
Nomura, M., Ohuchi, M., Sakamoto, Y., Kudo, K., Yaku, K., Soga, T., Sugiura, Y., Morita, M., Hayashi, K., Miyahara, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43630-3 · Cited by 29
Self-citationMeier, M., Nuciforo, S., Coto‐Llerena, M., Gallon, J., Matter, M. S., Ercan, C., Vosbeck, J., Terracciano, L., Soysal, S. D., Boll, D. T., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00150-3 · Cited by 25
Integration of Organoids With CRISPR Screens: A Narrative Review
Mukhare, R., Gandhi, K., Kadam, A., Raja, A., Singh, A., Madhav, M., Chaubal, R., Pandey, S., & Gupta, S. (2025) · Biology of the Cell · doi:10.1111/boc.70006 · Cited by 26
Paola, F. J. D., Calafato, G., Piccaluga, P. P., Tallini, G., & Rhoden, K. J. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15080394 · Cited by 25
Preclinical Models of Neuroendocrine Neoplasia
Sedlack, A. J. H., Saleh-Anaraki, K., Kumar, S., Ear, P. H., Lines, K. E., Roper, N., Pacák, K., Bergsland, E. K., Quelle, D. E., Howe, J. R., et al. (2022) · Cancers · doi:10.3390/cancers14225646 · Cited by 25
GLP-1R agonist promotes proliferation of neuroendocrine neoplasm cells expressing GLP-1 receptors
Shilyansky, J. S., Chan, C. J., Xiao, S., Gribovskaja‐Rupp, I., Quelle, D. E., Howe, J. R., Dillon, J. S., & Ear, P. H. (2024) · Surgery · doi:10.1016/j.surg.2024.09.052 · Cited by 23
Basal-shift transformation leads to EGFR therapy-resistance in human lung adenocarcinoma
Shinozaki, T., Togasaki, K., Hamamoto, J., Mitsuishi, A., Fukushima, T., Sugihara, K., Ebisudani, T., Okada, M., Saito, A., Shigematsu, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59623-3 · Cited by 26
Self-citationTran, C. G., Borbon, L. C., Mudd, J. L., Abusada, E., AghaAmiri, S., Ghosh, S. C., Vargas, S. H., Li, G., Beyer, G. V., McDonough, M., et al. (2022) · Cancers · doi:10.3390/cancers14081910 · Cited by 23
A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice
Caselli, E., Boni, M., Luca, D. D., Salvatori, D. C. F., Vita, A., & Cassai, E. (2004) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.10.001 · Cited by 23
Chronische Darmerkrankungen beim Hund: Eine Übersicht
Allenspach, K., & Gaschen, F. P. (2003) · Schweizer Archiv für Tierheilkunde · doi:10.1024/0036-7281.145.5.209 · Cited by 23
A New Perspective on Precision Medicine: The Power of Digital Organoids
Yang, Q., Li, M., Xiao, Z., Feng, Y., Lei, L., & Li, S. (2025) · Biomaterials Research · doi:10.34133/bmr.0171 · Cited by 23
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma
Ooki, A., Osumi, H., Fukuda, K., & Yamaguchi, K. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10121-2 · Cited by 24
Yang, R., Yao, Q., Kwan, W., Du, Y., Yan, R., Zang, L., Yao, X., Li, C., Zhu, Z., Zhang, X., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05512-0 · Cited by 24
Patte, C., Pommier, R. M., Ferrari, A., Chung, F. F., Ouzounova, M., Moullé, P., Richaud, M., Khoueiry, R., Hervieu, M., Breusa, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57305-8 · Cited by 24
An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
Bevere, M., Γκουντάκος, Α., Martelli, F. M., Scarpa, A., Luchini, C., & Simbolo, M. (2023) · Biomedicines · doi:10.3390/biomedicines11020303 · Cited by 27
Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions
Forsythe, S. D., Pu, T., Andrews, S. G., Madigan, J. P., & Sadowski, S. M. (2023) · Cancers · doi:10.3390/cancers15153756 · Cited by 23
New developments and applications of human organoids
Andersson-Rolf, A., & Clevers, H. C. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-026-00974-0 · Cited by 25
Smolková, B., Kataki, A., Earl, J., Ruz‐Caracuel, I., Cihova, M., Urbanova, M., Buociková, V., Tamargo, S., Rovīte, V., Niedra, H., et al. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103865 · Cited by 21
Tamagawa, H., Fujii, M., Togasaki, K., Seino, T., Kawasaki, S., Takano, A., Toshimitsu, K., Takahashi, S., Ohta, Y., Matano, M., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01498-5 · Cited by 22
Self-citationEx Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates
Herring, B., Jang, S., Whitt, J. D., Goliwas, K. F., Aburjania, Z., Dudeja, V., Ren, B., Berry, J. L., Bibb, J. A., Frost, A. R., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.710009 · Cited by 19
A human ACTH-secreting corticotroph tumoroid model
Zhang, D., Hugo, W., Redublo, P., Miao, H., Bergsneider, M., Wang, M. B., Kim, W. B., Yong, W. H., & Heaney, A. P. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103294 · Cited by 19
Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics
Corbett, V., Hallenbeck, P. L., Rychahou, P. G., & Chauhan, A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.930207 · Cited by 21
Pancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases
Liu, Y., Li, N., & Zhu, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044027 · Cited by 22
Organoid models: the future companions of personalized drug development
Piraino, F., Costa, M., Meyer, M., Cornish, G. H., Ceroni, C., Garnier, V., Hoehnel, S., & Brandenberg, N. (2024) · Biofabrication · doi:10.1088/1758-5090/ad3e30 · Cited by 21
Tanaka, H., Kanda, M., Miwa, T., Umeda, S., Sawaki, K., Tanaka, C., Kobayashi, D., Hayashi, M., Yamada, S., Nakayama, G., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01366-1 · Cited by 19
Rico, K., Duan, S., Pandey, R., Chen, Y., Chakrabarti, J. T., Starr, J., Zavros, Y. L., Else, T., Katona, B. W., Metz, D. C., et al. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000765 · Cited by 19
Viol, F., Sipos, B., Fahl, M., Clauditz, T. S., Amin, T., Kriegs, M., Nieser, M., Izbicki, J. R., Huber, S., Lohse, A. W., et al. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00727-z · Cited by 19
Feline combined diaphyseal radial and ulnar fractures
de la Puerta, B., Trayhorn, D., Moores, A. P., Langley-Hobbs, S. J., & Wallace, A. M. (2008) · Veterinary and Comparative Orthopaedics and Traumatology · doi:10.3415/vcot-08-02-0012 · Cited by 19
Living Biobanks of Organoids: Valuable Resource for Translational Research
Huang, W., Xu, Z., Li, S., Zhou, J., & Zhao, B. T. (2024) · Biopreservation and Biobanking · doi:10.1089/bio.2023.0142 · Cited by 19
Ku, C., Wuputra, K., Pan, J.-B., Li, C.-P., Liu, C., Liu, Y., Saito, S., Chan, T., Lin, C., Wu, D., et al. (2022) · Cells · doi:10.3390/cells11020184 · Cited by 18
Organoids as research models for hepatocellular carcinoma
Yu, J. H., & Ma, S. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112987 · Cited by 16
Long-term organoid culture of a small intestinal neuroendocrine tumor
D’Agosto, S. L., Fiorini, E., Pezzini, F., Delfino, P., Simbolo, M., Vicentini, C., Andreani, S., Capelli, P., Rusev, B. C., Lawlor, R. T., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.999792 · Cited by 18
Organoid Models for Cancer Research—From Bed to Bench Side and Back
Kastner, C., Hendricks, A., Deinlein, H., Hankir, M. K., Germer, C., Schmidt, S., & Wiegering, A. (2021) · Cancers · doi:10.3390/cancers13194812 · Cited by 18
Fukushima, T., Togasaki, K., Hamamoto, J., Emoto, K., Ebisudani, T., Mitsuishi, A., Sugihara, K., Shinozaki, T., Okada, M., Saito, A., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-00945-y · Cited by 16
Self-citation3D Models of Sarcomas: The Next-generation Tool for Personalized Medicine
Xu, R., Chen, R., Tu, C., Gong, X. Y., Liu, Z., Mei, L., Ren, X., & Li, Z. (2023) · Phenomics · doi:10.1007/s43657-023-00111-3 · Cited by 16
Tumor Organoids as a Research Tool: How to Exploit Them
Booij, T. H., Cattaneo, C. M., & Hirt, C. (2022) · Cells · doi:10.3390/cells11213440 · Cited by 17
Zhang, G., Liang, Q., Wu, Y., & Wang, Y. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5626 · Cited by 17
Huang, T. H., Huang, W. T., & Bian, Q. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114222 · Cited by 14
Metadata
- Authors
- Kawasaki, K., Toshimitsu, K., Matano, M., Fujita, M., Fujii, M., Togasaki, K., Ebisudani, T., Shimokawa, M., Takano, A., Takahashi, S., Ohta, Y., Nanki, K., Igarashi, R., Ishimaru, K., Ishida, H., Sukawa, Y., Sugimoto, S., Saito, Y., Maejima, K., Sasagawa, S., Lee, H., Kim, H.-G., Ha, K., Hamamoto, J., Fukunaga, K., Maekawa, A., Tanabe, M., Ishihara, S., Hamamoto, Y., Yasuda, H., Sekine, S., Kudo, A., Kitagawa, Y., Kanai, T., Nakagawa, H., & Sato, T.
- Affiliations
- Keio University (JP)
- RIKEN Center for Integrative Medical Sciences (JP)
- Seoul National University (KR)
- Tokyo Medical and Dental University (JP)
- The University of Tokyo (JP)
- National Cancer Center Hospital (JP)
- Corresponding author
- Sato, Toshiro
- ORCID
- Kawasaki, Kenta
- Matano, Mami
- Fujita, Masashi
- Fujii, Masayuki
- Togasaki, Kazuhiro
- Ebisudani, Toshiki
- Takano, Ai
- Takahashi, Sirirat
- Ohta, Yuki
- Nanki, Kosaku
- Ishimaru, Kazuhiro
- Sukawa, Yasutaka
- Sugimoto, Shinya
- Saito, Yoshimasa
- Kim, Hong-Gee
- Ha, Kyungsik
- Hamamoto, Junko
- Fukunaga, Koichi
- Maekawa, Aya
- Tanabe, Minoru
- Ishihara, Soichiro
- Hamamoto, Yasuo
- Yasuda, Hiroyuki
- Sekine, Shigeki
- Kudo, Atsushi
- Kitagawa, Yuko
- Nakagawa, Hidewaki
- Sato, Toshiro
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 183
- Issue
- 5
- Pages
- 1420-1435.e21
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3097717913
- Cited by
- 238
- References
- 71
- Citations by year
- 2026: 35 · 2025: 48 · 2024: 40 · 2023: 39 · 2022: 38 · 2021: 28 · 2020: 1
- FWCI
- 19.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Core Research for Evolutional Science and Technology
- Japan Agency for Medical Research and Development (19cm010654, 20cm0106576, 20ck0106471, JP20cm0106206)
- Japan Society for the Promotion of Science (JP17H06176)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Neuroblastoma Research and Treatments
- Keywords
- gastroenteropancreatic neuroendocrine tumors, neuroendocrine carcinoma, organoids, biobanks, genotype-phenotype mapping, TP53, RB1, loss of heterozygosity, transcription factors, molecular subtypes, colonic epithelium
- MeSH terms
- Whole Genome Sequencing, Animals, Chromosomes, Human, Genotype, Humans, Intestinal Neoplasms, Male, Models, Genetic, Mutation, Organoids, Pancreatic Neoplasms, Phenotype, Stomach Neoplasms, Biological Specimen Banks, Neuroendocrine Tumors, Intercellular Signaling Peptides and Proteins, Mice, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
